Role of G(M1) binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit

Immunology

Volumn 94, Issue 3, 1998, Pages 424-430

  De Haan, L ^a   Verweij, W R ^a   Feil, I K ^b   Holtrop, M ^a   Hol, W G J ^b   Agsteribbe, E ^a   Wilschut, J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; GANGLIOSIDE GM1; ADENOSINE DIPHOSPHATE RIBOSE; BACTERIAL TOXIN; ENTEROTOXIN; ENTEROTOXIN LT; ESCHERICHIA COLI PROTEIN; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE INFECTION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNIZATION; IMMUNOLOGY; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; METABOLISM; MUCOSAL IMMUNITY; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

ADENOSINE DIPHOSPHATE RIBOSE; ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, VIRAL; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; G(M1) GANGLIOSIDE; IMMUNITY, MUCOSAL; IMMUNIZATION; INFLUENZA A VIRUS; MICE; MICE, INBRED BALB C; MUTAGENESIS, SITE-DIRECTED; RECOMBINANT PROTEINS;

EID: 0031595032     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00535.x     Document Type: Article

References (33)

1. CLEMENTS J.D., HARTZOG N.M. & LYON F.L. (1988) Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6, 269.
2. ELSON C.O. & EALDING W. (1984) Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J Immunol 132, 2736.
3. ELSON C.O. & EALDING W. (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol 133, 2892.
4. LYCKE N. & HOLMGREM J. (1986) Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59, 301.
5. SNIDER D.P. (1995) The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit Rev Immunol 15, 317.
6. SPANGLER B.D. (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56, 622.
7. SEARS C.L. & KAPER J.B. (1996) Enteric bacterial toxins: mechanism of action and linkage to intestinal secretion. Microbiol Rev 60, 167.
8. PIZZA M., FONTANA M.R., GIULIANI M.M. et al. (1994) A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med 180, 2147.
9. DOUCE G., TURCOTTE C., CROPLEY I. et al. (1995) Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 92, 1644.
10. DICKINSON B.L. & CLEMENTS J.D. (1995) Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63, 1617.
11. DI TOMMASO A., SALETTI G., PIZZA M. et al. (1996) Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun 64, 974.
12. DEHAAN L., VERWEIJ W.R., FEIL I.K. et al. (1996) Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin. Infect Immun 64, 5413.
13. VADOLAS J., DAVIES J.K., WRIGHT P.J. & STRUGNELL R.A. (1995) Intranasal immunization with liposomes induces strong mucosal immune responses in mice. Eur J Immunnol 25, 969.
14. TAMURA S.-I., YAMANAKA A., SHIMOHARA M. et al. (1994) Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12, 419.
15. TAMURA S.-I., ASANUMA H., TOMITA T. et al. (1994) Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 12, 1083.
16. LYCKE N., TSUJI T. & HOLMGREN J. (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22, 2277.
17. YAMAMOTO S., TAKEDA Y., YAMAMOTO M. et al. (1997) Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J Exp Med 185, 1203.
18. YAMAMOTO S., KIYONO H., YAMAMOTO M. et al. (1997) A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 94, 5267.
19. VERWEIJ W.R., DEHAAN L., HOLTROP M. et al. (1989) Mucosal immunoadjuvant activity of the recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine, in press.
20. HAZAMA M., MAYUMI-AONO A., MIYAZAKI T., HINUMA S. & FUJISAWA Y. (1993) Intranasal immunization against herpes simplex virus by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology 78, 643.
21. TOCHIKUBO K., ISAKA M., YASUDA Y. et al. (1998) Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 16, 150.
22. WU H.-Y. & RUSSELL M.W. (1998) Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16, 286.
23. DEHAAN L., VERWEIJ W.R., HOLTROP M., AGSTERIBBE E. & WILSCHUT J. (1996) Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: Role of the A subunit. Vaccine 14, 260.
24. UESAKA Y., OTSUKA Y., LIN Z. et al. (1994) Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb Pathol 16, 71.
25. DERTZBAUGH M.T. & ELSON C.O. (1993) Reduction in oral immunogenicity of cholera loxin B subunit by N-terminal peptide addition. Infect Immun 61, 384.
26. FEIL I.K., REDDY R., DEHAAN L. et al. (1996) Protein engineering studies of A-chain loop 47 of E. coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. Mol Microbiol 20, 823.
27. SOMAN G., NARAYANAN J., MARTIN B.L. & GRAVIS D.J. (1986) Use of substituted benzylidineamino-guanidines in the study of guanidino group specific ADP-ribosyltransferase. Biochemistry 25, 4113.
28. NASHAR T.O. WEBB H.M., EAGLESTONE S., WILLIAMS N.A. & HIRST T.R. (1996) Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: Receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc Natl Acad Sci USA 93, 226.
29. DE HAAN L., VKRWEIJ W.R., HOLTROP M. et al. (1998) Nontoxic variants of the Escherichia coli heat-labile enterotoxin as mucosal immunogens and adjuvants. STP Pharma Sciences 8, 75.
30. JOBLING M.G. & HOLMES R.K. (1991) Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis. Mol Microbiol 5, 1755.
31. GUIDRY J.J., CARDENAS L., CHENG E. & CLEMENTS J.D. (1997) Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infect Immun 65, 4943.
32. HOLMGREN J., FREDMAN P., LINDBLAD M., SVENNERHOLM A.M. & SVENNERHOLM L. (1982) Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun 38, 424.
33. TENEBERG S., HIRST T.R., ANGSTROM J. & KARLSSON K.A. (1994) Comparison of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine. Glycocon J 11, 533.